South Australian drug discovery company GroPep (ASX:GRO) has begun selling off sections of its newly acquired intellectual property treasure chest. [ + ]

Victoria's government has backed stem cell research despite its existing ban on embryonic cell studies. [ + ]

Drug developer Amrad Corporation has raised $15.5 million in capital to help progress its clinical trials program. [ + ]

Australian biotechnology company BresaGen's half-year results to December 2001 show an increase in revenue by 15 per cent, to $3,661,000, over the same period a year ago. [ + ]

Dental research group SDI has reported a half-yearly jump in profits and sales on the back of its suite of aesthetic and alloy restorative products. [ + ]

Agriculture Victoria's 40-year bantamised hen project has entered the commercialisation phase, beginning a joint research deal with an elite international breeder. [ + ]

Australian researchers were wasting 90 per cent of their intellectual property value because they did not understand how to use it, a patent attorney has warned. [ + ]

A screening instrument that enables drug company technicians to run parallel tests has been released by Melbourne-based company Axon Instruments (ASX: AXN). [ + ]

The world's leading non-profit funder of diabetes research was in Australia this week (February 27) to seek out Australian stem cell scientists. [ + ]

Innovation is the 21st Century driver for economic growth, high quality jobs, wealth and improved living standards, the Minister for Innovation, John Brumby, has said. [ + ]

Brisbane biotech business Xenome Ltd is moving closer to human trials with a pain-killing molecule derived from the venom of a marine shellfish. [ + ]

Backing hopeful young companies into the listed shells of mining companies is an old habit in Western Australia. [ + ]

Australia's biotechnology companies will have to merge or perish, according to leading industry analyst Ernst and Young. [ + ]

There are fears the current insurance industry upheaval will force some biotechs to the wall unless the Gene Technology Act 2000 is overhauled. [ + ]

US-based genetics company, Sequenom, has chosen Queensland as the location for its Asia-Pacific regional headquarters, Premier Peter Beattie has announced. [ + ]